Smartphones, tablets stepping up as diagnostic technology options
March 6, 2020
New technology is good if it does what it purports to do and sometimes goes beyond that.
All Content
If medications fail, surgery option for treating infectious retinitis
February 28, 2020
Viral retinitis is a rare disease that implies involvement of Herpesviridae, a family of double-stranded DNA viruses characterized by latency within the host’s cells after the primary infection, accordin
Lab tear tests aid reimbursements, clinical application of dry eye
February 27, 2020
When a physician seeks to determine a diagnosis and subsequent course of action for a patient, the clinical value of every step in that process is first and foremost.
Li Wenliang: Ophthalmologist hero
February 26, 2020
Much attention these days is focused on the epidemic being caused by a novel coronavirus that originated in Wuhan, China.
Changing focus of accommodating IOLs now reaching a new level
February 25, 2020
This article was reviewed by Stephen D. McLeod, MD
Change is a constant and with change in accommodating IOLs comes potential improvements in vision for presbyopic patients.
Researchers reaching for the stars to cure presbyopia
February 24, 2020
This article was reviewed by Susana Marcos, PhD
A poor husband's vision
February 22, 2020
AMD awareness: Close focus on preserving vision
February 21, 2020
Awareness of the development of age-related macular degeneration (AMD) has been increasing slowly with the recognition of the advancing age of the population.
New techniques probed for managing dry eye disease
February 21, 2020
Dry eye disease has become a public health issue, with increasing prevalence in the United States, where more than 16 million people are affected.
PRN ranibizumab outcomes over the long term in real world
February 20, 2020
Nearly 50% of eyes with wet age-related macular degeneration (AMD) have stable or improved vision after long-term, 8-year pro re nata (PRN) treatment with ranibizumab, according to a group of U.K. clinicians.
